Ginsenosides not only improve glucose metabolism, increase insulin sensitivity, and promote lipid transport, but also alleviate symptoms of obesity-related complications like diabetes and NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.